Keratin
Keratin is not a single protein but a large family – 54 genes encode distinct keratin isoforms in humans, all forming intermediate filaments that provide mechanical strength to epithelial cells. In skin, keratin pairs shift as keratinocytes differentiate upward from the basal layer: K5/K14 in dividing basal cells, K1/K10 in differentiating suprabasal cells, and a distinct set of wound-associated keratins (K6, K16, K17) that replace K1/K10 at injury sites to enable keratinocyte migration and repair. In hair, a separate subfamily of hard keratins – the trichocyte keratins – forms the cortex, cuticle, and medulla of the hair shaft, with cysteine-derived disulfide bonds providing the mechanical properties of the fibre. Keratin’s structural integrity depends on the amino acid substrate available (particularly cysteine and glycine), the quality of the differentiation programme that produces it, and the inflammatory environment – all of which can be addressed through targeted nutrition, homecare, and professional treatment. The clinical relevance extends from understanding why compromised skin resilience and hair shaft quality respond to specific interventions, to understanding why wound healing and post-procedure recovery depend on the same keratin isoform switching mechanism the body uses to manage all epithelial injury.
Keratin proteins form the intermediate filament (IF) cytoskeleton of all epithelial cells – the structural scaffold that sits between the actin microfilaments and microtubules of the cytoskeleton in terms of diameter (approximately 10nm) and that is uniquely responsible for the mechanical resilience of surface-exposed tissues. All 54 human keratin genes encode proteins of two types: type I (acidic, encoded by genes KRT9–KRT28) and type II (basic/neutral, encoded by KRT1–KRT8 and KRT71–KRT86). Keratins always form obligate heterodimers – a type I and a type II keratin coil together to form a coiled-coil dimer, two dimers form a tetramer, and tetramers polymerise into the 10nm intermediate filament that integrates into the cell’s structural network. No single keratin type functions in isolation: the pairing is both obligatory and specific, with different pairings characteristic of different cell types, differentiation stages, and injury states. [5]
Epidermal Keratins: The Differentiation Programme
The epidermis expresses a precisely regulated sequence of keratin pairs that shift as keratinocytes migrate from basal layer to stratum corneum. This sequential expression is not incidental – each pair fulfils mechanically and functionally distinct roles at the differentiation stage it occupies.
K5/K14 – the basal keratin pair – are expressed exclusively in the mitotically active basal keratinocytes. They form the intermediate filament network that anchors basal cells to the basement membrane via hemidesmosomes and to adjacent cells via desmosomes, providing mechanical resistance to shear forces at the dermo-epidermal junction. K14 is a marker of basal keratinocyte identity and proliferative capacity; K5 and K14 together modulate cell proliferation through the PI3K/Akt pathway and negatively regulate the differentiation programme through Notch1 signalling – making the K5/K14 pair not merely structural but actively regulatory of the basal-to-suprabasal transition. [1]
K1/K10 – the suprabasal differentiation pair – replace K5/K14 as keratinocytes commit to terminal differentiation and move into the spinous and granular layers. K10 expression specifically inhibits cell cycle progression and promotes terminal differentiation, whilst K1/K10 filaments reorganise from the loosely bundled array of basal cells into the densely bundled keratin pattern characteristic of the differentiating epidermis. This structural reorganisation is required for the downstream events of cornification – including the processing of profilaggrin and the formation of the cornified envelope. Research in K10-null mice demonstrated that loss of K10 impairs profilaggrin processing, confirming that intact keratin filament architecture is a prerequisite for the normal NMF production cascade. [7]
The Wound-Associated Keratin Shift
One of the most clinically relevant aspects of keratin biology is the isoform shift that occurs immediately at the wound edge. Within hours of epithelial injury – whether from surgery, ablative laser treatment, microneedling, or physical trauma – keratinocytes at the wound margin dramatically reduce K1/K10 expression and upregulate a distinct set of five wound-associated keratins: K6A, K6B, K6C, K16, and K17. This switch is not incidental to the repair process; it is the molecular mechanism that enables it. [6]
K6 and K16 together provide the balance between intercellular adhesion and migratory plasticity that wound closure requires – high K6A expression is directly associated with faster keratinocyte migration into the wound gap, confirmed in three-dimensional epidermal culture models. K17 drives cell proliferation and migration through STAT3 signalling and modulates lipid metabolism in keratinocytes to restore barrier function as the wound closes. K6/K16/K17 expression is maintained at elevated levels throughout all stages of re-epithelialisation and normalises only when epithelial barrier function is fully restored. [8]
The clinical implication is precise: the K1/K10 to K6/K16/K17 switch is what the epidermis does when it needs to move rather than differentiate. Treatments that disrupt this switch – or that fail to provide the cellular environment in which it can proceed – slow re-epithelialisation. Treatments that support the wound-healing keratin environment accelerate it.
Clinical Pearl K6 (wound-induced keratin) interacts directly with Src tyrosine kinase and regulates cell-matrix adhesion, a key determinant of keratinocyte migration speed. This is not a general wound-healing signal – it is a specific keratin-mediated regulatory mechanism. It explains why the quality of the keratinocyte cytoskeletal response to injury, not just the growth factor environment, determines how rapidly the epidermis closes.
Hard Keratins: Hair and Nails
Hair and nails are built from a distinct subfamily of keratins – the trichocyte keratins (also called hard keratins), encoded by KRT31–KRT40 (type I) and KRT81–KRT86 (type II). These differ from the soft epithelial keratins of the epidermis primarily in their much higher cysteine content – approximately 14–22% of their amino acid residues – which allows dense disulfide cross-linking between adjacent chains to produce the rigid, chemically resistant structure of the mature hair fibre and nail plate. [4]
In the hair follicle, trichocyte keratins are synthesised exclusively by the cortical cells differentiated from the matrix cells in the follicle bulb during anagen. As these cells undergo programmed apoptosis and keratinisation in the keratogenous zone above the bulb, the reducing environment of the matrix transitions to the oxidising environment of the hardening zone – triggering the formation of disulfide bonds between cysteine residues on adjacent keratin chains. This oxidative cross-linking event locks the protein scaffold into the final structure of the hair cortex and cuticle, producing the tensile strength and elasticity characteristic of the mature hair shaft. The density and distribution of these cross-links – determined by cysteine availability and the oxidative environment of keratinisation – directly determines the mechanical properties of the resulting fibre. [2]
Keratin proteins secreted by outer root sheath (ORS) cells during the catagen phase also play an active signalling role in hair cycle progression. Research has identified that keratin released by TGFβ2-induced apoptotic ORS cells provides a cue for dermal papilla condensation and new hair germ formation – suggesting that keratin is not merely a passive structural outcome of follicle activity but an active participant in the signalling that initiates the next anagen cycle. In vivo knockdown of KRT31/KRT34 in mice suppressed anagen hair follicle formation and hair growth, an effect rescued by intradermal injection of exogenous keratin – directly confirming the signalling role. [2]
When Keratin Fails: Mutation and Disease Context
The functional consequences of keratin disruption are most clearly demonstrated in the genodermatoses – inherited skin fragility disorders caused by keratin gene mutations. Epidermolysis bullosa simplex (EBS) results from dominant missense mutations in KRT5 or KRT14 – the basal epidermal keratins. Even a single abnormal keratin molecule integrated into the K5/K14 intermediate filament network is sufficient to impair cytoskeletal function and elicit epidermal fragility and blistering under mechanical stress – demonstrating that the filament network’s mechanical integrity depends on the precision of every keratin molecule within it, not just the majority. [10]
Mutations in K1/K10 cause epidermolytic ichthyosis, where failure of the suprabasal keratin network disrupts cornification and produces the characteristic epidermolytic blistering pattern. These genetic conditions, though rare, provide the clearest available evidence for what keratin integrity enables – they define the biological floor below which mechanical resilience, barrier function, and normal desquamation cannot be maintained. [3]
Keratin and Nutrition
Keratin synthesis demands substantial amino acid substrate, with hard keratins in hair and nails making disproportionately high demands on cysteine relative to soft epidermal keratins. The rate-limiting substrate constraints on keratin quality mirror those on collagen – cysteine availability determines disulfide cross-link density in hair keratin; glycine and serine availability from the same dietary protein pool influence the proliferative and differentiation programme that produces epidermal keratins. Under caloric restriction, rapid weight loss, or GLP-1 receptor agonist-related appetite suppression, both the substrate availability for keratin synthesis and the cysteine-derived glutathione pool protecting matrix cells from oxidative stress decline simultaneously – a dual impact that is reflected in the hair shaft quality and skin resilience changes commonly observed in these populations.
Clinical Application
The treatment framework for keratin divides along the same structural line as the protein itself – epidermal soft keratins and hair shaft hard keratins have different clinical presentations, different rate-limiting constraints, and different treatment relevance, though several interventions address both through shared upstream mechanisms.
Understanding the Clinical Problem
For epidermal keratin, the primary clinical manifestations of compromise are surface texture irregularity, reduced mechanical resilience (skin that marks, creases, or recovers slowly from mechanical deformation), and delayed wound re-epithelialisation after procedures. These presentations reflect failure at different points in the keratin programme: texture irregularity typically reflects disordered differentiation-stage keratin switching; resilience loss reflects compromised K5/K14 network integrity in the basal layer or reduced K1/K10 density in the suprabasal layers; delayed re-epithelialisation reflects impaired K6/K16/K17 wound-associated keratin upregulation or inadequate keratinocyte migration speed.
For hair shaft hard keratin, the primary presentations are reduced tensile strength (increased breakage), reduced diameter (shaft thinning), loss of surface cuticle integrity (roughness, reduced light reflection), and in more significant substrate deficiency, reduced anagen duration. These reflect failure at the substrate level (cysteine shortage reducing disulfide cross-link density), the matrix cell level (oxidative stress impairing synthesis in rapidly dividing cells), or the follicle signalling level (impaired keratin-mediated dermal papilla condensation signalling).
Treatments Addressing Epidermal Keratin Quality
Microneedling and RF microneedling activate the wound-associated keratin programme – the K6/K16/K17 upregulation that drives keratinocyte migration, proliferation, and barrier restoration – in a controlled, repeatable manner. The needle channels create micro-injury sufficient to trigger the full keratin isoform switch without the extended recovery of ablative treatments. RF microneedling adds a thermal signal that activates a second wave of keratinocyte differentiation-programme stimulation in the mid-dermal zone. The clinical benefit for skin texture and resilience operates partly through direct keratinocyte activation and partly through the collagen synthesis that the same wound-healing cascade drives in the underlying dermis. [6]
Thulium fractional laser produces microscopic thermal zones (MTZs) in the epidermis that trigger rapid re-epithelialisation from the untreated keratinocyte reservoir. The regenerative wave that closes each MTZ involves full keratin isoform switching – K6/K16/K17 upregulation followed by restoration of K1/K10 as the wound closes and differentiation resumes. Critically, thulium laser activates COL17A1 expression in follicular reservoir keratinocytes – COL17A1 being the transmembrane collagen that anchors basal keratinocytes and co-localises with K5/K14 at the basement membrane. This COL17A1/K5/K14 reactivation in the reservoir population is what regenerates the basal keratinocyte quality that makes the subsequent epidermal renewal more structurally competent. [5]
Polynucleotides address the keratinocyte differentiation environment through macrophage reprogramming and the downstream cytokine shift from pro-inflammatory to pro-regenerative signalling. The M2 macrophage polarisation that polynucleotides drive produces IL-10 and TGF-β, both of which support keratinocyte differentiation and barrier restoration. Separately, polynucleotide treatment via adenosine A2A receptor activation has been shown to support the keratinocyte proliferation required for epidermal integrity – making polynucleotides a useful upstream environment-preparation step before more direct keratinocyte stimulation treatments.
Treatments Addressing Hair Keratin Quality
iPRF on the scalp provides the growth factor environment – PDGF, EGF, TGF-β, IGF-1 – that supports both matrix cell proliferation and the ORS cell health on which keratin signalling for dermal papilla condensation depends. The fibronectin component of iPRF, which is measurably higher than in standard PRP preparations, supports cell-matrix adhesion in the follicle environment during the critical transition from catagen to telogen. For clients with reduced hair shaft diameter or increased breakage alongside shedding, the matrix cell support from iPRF addresses both the signalling environment for anagen initiation and the substrate quality of the keratin being produced. [9]
Nutritional support is the only intervention that directly addresses the cysteine substrate deficit constraining hard keratin cross-link density. Where hair shaft quality decline accompanies weight loss, caloric restriction, or GLP-1 medication use, ensuring adequate dietary cysteine (or methionine as its precursor) and total protein intake is a prerequisite for any professional treatment to operate in a fully resourced substrate environment. N-acetylcysteine (NAC) supplementation addresses both the cysteine substrate shortage and the glutathione depletion that increases oxidative stress in matrix cells – the two mechanisms through which protein restriction impairs hair keratin quality simultaneously.
Matching Treatment to Presentation
| Presentation | Primary mechanism | Treatment priority |
|---|---|---|
| Surface texture irregularity, dull skin | Disordered K1/K10 differentiation programme | Microneedling, thulium laser, exosomes |
| Reduced skin resilience, slow mechanical recovery | Compromised K5/K14 basal network | RF microneedling, polynucleotides, LED red light |
| Delayed post-procedure re-epithelialisation | Impaired K6/K16/K17 wound keratin upregulation | Polynucleotides (pre-treatment), nutritional assessment |
| Hair shaft thinning, increased breakage | Reduced disulfide cross-link density (cysteine) | Nutritional support (cysteine/protein), iPRF |
| Hair shedding with shaft quality changes | Matrix cell oxidative stress + substrate shortage | NAC supplementation, iPRF, nutritional review |
| Post-weight-loss hair and skin changes | Compound substrate deficiency (cysteine, glycine, serine) | Nutritional repletion first, then professional treatment |
References
Alam H, Sehgal L, Kundu ST, et al. (2011). Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cells. Mol Biol Cell, 22(21), 4068-78 . doi.org/10.1091/mbc.e10-08-0703
An SY, Kim HS, Kim SY, et al. (2022). Keratin-mediated hair growth and its underlying biological mechanism. Commun Biol, 5(1), 1270 . doi.org/10.1038/s42003-022-04232-9
Eady RA, Dunnill MG (1994). Epidermolysis bullosa: hereditary skin fragility diseases as paradigms in cell biology. Arch Dermatol Res, 287(1), 2-9 . doi.org/10.1007/bf00370710
Harland DP, Popescu C, Richena M, et al. (2022). The susceptibility of disulfide bonds to modification in keratin fibers undergoing tensile stress. Biophys J, 121(11), 2168-2179 . doi.org/10.1016/j.bpj.2022.04.029
Jacob JT, Coulombe PA, Kwan R, et al. (2018). Types I and II Keratin Intermediate Filaments. Cold Spring Harb Perspect Biol, 10(4) . doi.org/10.1101/cshperspect.a018275
Nanes BA, Bhatt K, Azarova E, et al. (2024). Shifts in keratin isoform expression activate motility signals during wound healing. Dev Cell, 59(20), 2759-2771.e11 . doi.org/10.1016/j.devcel.2024.06.011
Reichelt J, Büssow H, Grund C, et al. (2001). Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice. Mol Biol Cell, 12(6), 1557-68 . doi.org/10.1091/mbc.12.6.1557
Romashin DD, Tolstova TV, Varshaver AM, et al. (2024). Keratins 6, 16, and 17 in Health and Disease: A Summary of Recent Findings. Curr Issues Mol Biol, 46(8), 8627-8641 . doi.org/10.3390/cimb46080508
Song W, Peng M, Ma Q, et al. (2025). The Skin Microenvironment: A Dynamic Regulator of Hair Follicle Development, Cycling and Disease. Biomolecules, 15(9) . doi.org/10.3390/biom15091335
Wally V, Welponer T, Wiesinger HP, et al. (2025). Keratin-associated epidermolysis bullosa simplex: phenotypes and challenges in clinical trials – a narrative review and systematic update. Orphanet J Rare Dis, 20(1), 313 . doi.org/10.1186/s13023-025-03822-0
Biological Relationships
Influenced By
- this Produced by Hair follicle Evidence: Matrix keratinocytes differentiate upward to form the hair shaft composed of keratin; keratinisation is the primary anagen-phase output. Natarelli et al. (2023) J Clin Med 12(3):893. doi:10.3390/jcm12030893
- this Produced by Keratinocyte Evidence: Keratinocytes produce keratin intermediate filaments (K5/K14 basal K1/K10 suprabasal) as primary structural scaffold throughout differentiation. Standard keratinocyte biology.
Learn More
This topic is discussed in 2 articles:
-
-
Keratin is the family of structural proteins that form the intermediate filaments of skin, hair, and nails, providing mechanical strength and showing distinct expression patterns during repair.